Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Millions	Jan. 31, 2025	Oct. 31, 2024
Current assets:
Cash, cash equivalents and restricted cash	$ 2,894	$ 3,253
Accounts receivable, net of allowance for credit losses of $84 and $83, as of January 31, 2025 and October 31, 2024, respectively	4,188	5,117
Inventory	8,443	7,720
Other current assets	4,309	4,670
Total current assets	19,834	20,760
Property, plant and equipment, net	2,900	2,914
Goodwill	8,599	8,627
Other non-current assets	7,597	7,608
Total assets	38,930	39,909
Current liabilities:
Notes payable and short-term borrowings	1,418	1,406
Accounts payable	16,483	16,903
Other current liabilities	9,533	10,378
Total current liabilities	27,434	28,687
Long-term debt	8,273	8,263
Other non-current liabilities	4,295	4,282
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01 par value (9,600 shares authorized; 945 and 939 shares issued and outstanding as of January 31, 2025 and October 31, 2024, respectively)	9	9
Additional paid-in capital	1,874	1,778
Accumulated deficit	(2,751)	(2,676)
Accumulated other comprehensive loss	(204)	(434)
Total stockholders’ deficit	(1,072)	(1,323)
Total liabilities and stockholders’ deficit	$ 38,930	$ 39,909